E. Premkumar Reddy
Director/Board Member at Translational Development Acquisition Corp.
Profile
E.
Premkumar Reddy is the founder of Onconova Therapeutics, Inc., which was founded in 1998.
He held the title of Director at Onconova Therapeutics, Inc. from 1999 to 2020.
Currently, Dr. Premkumar Reddy holds the position of Professor & Director-Cancer Therapeutics Program at Icahn School of Medicine at Mount Sinai since 2013.
He is also the Director-Experimental Cancer Therapeutics Program at The Tisch Cancer Institute at Mount Sinai since 2010.
Additionally, he is a Director at Translational Development Acquisition Corp.
Previously, Dr. Premkumar Reddy worked as the Director & Professor at Fels Institute of Government from 1992 to 2010.
Dr. Premkumar Reddy completed his undergraduate, graduate, and doctorate degrees at Osmania University.
E. Premkumar Reddy active positions
| Companies | Position | Start |
|---|---|---|
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 2010-02-28 |
| The Tisch Cancer Institute at Mount Sinai | Corporate Officer/Principal | 2010-02-28 |
Translational Development Acquisition Corp.
 Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY. | Director/Board Member | - |
Former positions of E. Premkumar Reddy
| Companies | Position | End |
|---|---|---|
| TRAWS PHARMA, INC. | Founder | 2020-08-26 |
| Fels Institute of Government | Director/Board Member | 2010-01-31 |
Training of E. Premkumar Reddy
| Osmania University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| The Tisch Cancer Institute at Mount Sinai | |
Translational Development Acquisition Corp.
Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- E. Premkumar Reddy
